Century Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-83,907
Closed -$1.75M 217
2016
Q3
$1.75M Sell
83,907
-113,318
-57% -$1.31M 0.22% 161
2016
Q2
$2.13M Buy
+197,225
New +$1.69M 0.24% 155

Century Capital Management's VTAE Position: Q4 2016 in Review

Century Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 83,907 shares — an estimated $1.75M sold.

Century Capital Management first reported a position in VTAE in Q2 2016 and held it in 2 quarters. The position peaked at $2.13M in Q2 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Century Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Century Capital Management sold 83,907 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $1.75M.
  • Century Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2016 and held it in 2 quarters.
  • Century Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $2.13M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Century Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.